DWS CROCI US C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
DWS CROCI U.S. Fund - Class C DCUCX
- NAV / 1-Day Return 15.92 / +0.76 %
- Total Assets 755.9M
-
Adj. Expense Ratio
1.810%
- Expense Ratio 1.840%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Large Value
- Investment Style Mid Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.45%
- Turnover 76%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 2:34 AM GMT+0
Morningstar’s Analysis DCUCX
Will DCUCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the DCUCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of DCUCX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 32.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Alphabet Inc Class A | 3.95 | 28M | Communication Services |
The Kraft Heinz Co | 3.62 | 26M | Consumer Defensive |
Bristol-Myers Squibb Co | 3.44 | 25M | Healthcare |
Cognizant Technology Solutions Corp Class A | 3.42 | 25M | Technology |
Fox Corp Class A | 3.37 | 24M | Communication Services |
Devon Energy Corp | 3.25 | 23M | Energy |
Qualcomm Inc | 3.21 | 23M | Technology |
Pfizer Inc | 2.81 | 20M | Healthcare |
State Street Corp | 2.73 | 20M | Financial Services |
Merck & Co Inc | 2.67 | 19M | Healthcare |
United States